Nath Bio-Genes (NATHBIOGEN)
₹216
INR+5.29(+2.51%)
As of July 4, 2025 9:45:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹412.76 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹302.90 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
10.87
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
-3.20
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.13
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
123.71%
Operating Margin
Operating income as a percentage of revenue
-1.79%
Return on Equity
Net income as a percentage of shareholders' equity
6.07%
Revenue (TTM)
Total revenue over trailing 12 months
₹364.91 Cr+20.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹54.34 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹19.85+32.4%
Balance Sheet
Total Cash
Total cash and short-term investments
₹88.90 Cr
Total Debt
Total short-term and long-term debt
₹122.50 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
19.01%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹137.55 - ₹264.31
Beta
Measure of stock's volatility compared to the market
0.44
Shares Outstanding
Total number of shares issued by the company
₹1.90 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
3.71%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.93%
Payout Ratio
Percentage of earnings paid as dividends
10.07%
